ConductScience.org, home

Trial · NCT06974916

EMBRACE Tremor BiFUS

NCT06974916, Not applicable, Recruiting, InSightec

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. EMBRACE Tremor BiFUS. Trials, record NCT06974916. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06974916

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
EMBRACE Tremor BiFUS
NCT number
NCT06974916
Status
Recruiting
Phases
Not applicable
Enrollment
100 participants, estimated
Lead sponsor
InSightec
Conditions
Essential Tremor
Interventions
Staged bilateral Exablate thalamotomy, Local standard medical treatment after previous Exablate unilateral thalamotomy.
First posted
2025-05-16
Last updated
2026-08-31

Source ClinicalTrials.gov

Registered outcomes17

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryTreated Upper Limb Clinical Rating Scale for Tremor (CRST) (A+B) (0-28) score for the treated side.6 MonthsThe primary endpoint is the difference of the Treated Upper Limb CRST (A+B) score between groups at 6 months. Higher score means a worse tremor.
SecondaryTreated Upper Limb Clinical Rating Scale for Tremor (CRST) (A+B) (0-28) score as assessed by the blinded reviewers of the video-recordings.6 Months, 12 Months
Between group comparison through month 6 and within group comparison vs baseline up to month 12 in Treated Upper Limb CRST (A+B) score as assessed by the blinded reviewers of the video-recordings. Higher score means a worse tremor.
SecondaryClinical Rating Scale for Tremor (CRST) part A (0-76)6 Months, 12 Months
Between group comparison through month 6 and within group comparison vs baseline up to month 12 in resting, postural, and action tremors of all items as measured by CRST part A. Higher score means a worse tremor.
SecondaryBilateral Upper Limb Clinical Rating Scale for Tremor (CRST) (A+B) (0-56)6 Months, 12 MonthsBetween group comparison through month 6 and within group comparison vs baseline up to month 12 in Bilateral Upper Limb CRST (A+B). Higher score means a worse tremor.
SecondaryTotal Clinical Rating Scale for Tremor (CRST) (A+B) (0-116)6 Months, 12 MonthsBetween group comparison through month 6 and within group comparison vs baseline up to month 12 in Total CRST (A+B). Higher score means a worse tremor.
SecondaryClinical Rating Scale for Tremor (CRST) part C (0-32)6 Months, 12 MonthsBetween group comparison through month 6 and within group comparison vs baseline up to month 12 in functional disabilities as measured by CRST part C. Higher score means a worse tremor.
SecondaryAxial Clinical Rating Scale for Tremor (CRST) (0-20)6 Months, 12 MonthsBetween group comparison through month 6 and within group comparison vs baseline up to month 12 in Axial CRST defined as face, tongue, head tremor and voice items of CRST part A
SecondaryQuality of life questionnaire6 Months, 12 MonthsBetween group comparison through month 6 and within group comparison vs baseline up to month 12 in disease specific QOL
SecondaryChange of tremor medication6 Months, 12 MonthsBetween group comparison through month 6 and within group comparison vs baseline up to month 12 in tremor medication change
SecondarySafety: Incidence and frequency of adverse events related to the treatment.6 Months, 12 Months
Incidence and frequency of adverse events related to the treatment and/or procedure. The investigator will capture any untoward events in the case report forms along with severity, duration, and resolution, and whether the event is considered serious. The severity of adverse events will be categorized according to the definition of adverse events from the International Organization for Standardization (ISO).

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT06974916

GET https://conductscience.org/api/trials/v1/NCT06974916/registered